Trials / Completed
CompletedNCT04298151
Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients
Clinical Evaluation of Zirconia Reinforced Versus Conventional Viscous Glass Ionomer in Posterior Restorations of Geriatric Patients: Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities
Detailed description
This study will be conducted to determine the clinical performance of the Zirconia reinforced glass ionomer restorations ( Zirconomer improved) under stress bearing posterior area (class I or claa II cavities) in geriatric population in comparison to Conventional viscous glass ionomer restorations (Ketac molar quick Aplicap) using the modified United States Public Health Service (USPHS) criteria P: Geriatric Patients with posterior Caries lesions I: Zirconia reinforced GI (Zirconomer Improved) C: Conventional viscous GI, (Ketac Molar quick Aplicap) O: The Clinical performance of the Glass Ionomer restorations Using USPHS Criteria
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zirconomer Improved | glass ionomer restoration reinforced with nano-zirconia particles to improve strength and esthetics |
| DRUG | Ketac Molar quick Aplicap | highly viscous glass ionomer with improved mechanical properties than the conventional GI |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-09-01
- Completion
- 2022-10-01
- First posted
- 2020-03-06
- Last updated
- 2024-02-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04298151. Inclusion in this directory is not an endorsement.